Search

everythinglearnresearchcommunity

for

Search:↓

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

Vitamin D receptor helps control hair growth genes in skin cells.

Redheaded people have higher levels of a vitamin D precursor, suggesting red hair may be an adaptation for better vitamin D synthesis in areas with less sunlight.

1α,25-dihydroxyvitamin D3 directly affects cartilage growth and development.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Mice without the vitamin D receptor are more prone to UV-induced skin tumors.

Mesotherapy might be a useful addition to dental surgery to reduce drug use and side effects, but more research is needed.

Metabolites and diet affect hair growth cycles in cashmere goats.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

No treatment fully prevents hair loss from chemotherapy yet.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Parathyroid hormone-related protein helps control hair growth phases in mice.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

The proteins transthyretin and megalin are more present in the growth phase of hair, suggesting they might affect hair health and growth.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The vitamin D receptor can act without its usual activating molecule, affecting hair growth and skin cancer, but its full range of actions is not well understood.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.